BriaCell Therapeutics Corp Stock price
Is BriaCell Therapeutics Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
BriaCell Therapeutics Corp Stock Analysis
Analyst Opinions
5 Analysts have issued a BriaCell Therapeutics Corp forecast:
Analyst Opinions
5 Analysts have issued a BriaCell Therapeutics Corp forecast:
Don't miss a Thing! We will send you all news about BriaCell Therapeutics Corp directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
BriaCell Therapeutics Corp Stock News
Company Profile
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
| Head office | Canada |
| CEO | Dr. Williams |
| Employees | 16 |
| Founded | 2006 |
| Website | briacell.com |


